##gff-version 3
##sequence-region P31213 1 254
P31213	UniProtKB	Chain	1	254	.	.	.	ID=PRO_0000213676;Note=3-oxo-5-alpha-steroid 4-dehydrogenase 2	
P31213	UniProtKB	Transmembrane	8	28	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P31213	UniProtKB	Transmembrane	72	92	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P31213	UniProtKB	Transmembrane	146	166	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P31213	UniProtKB	Transmembrane	206	226	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P31213	UniProtKB	Natural variant	5	5	.	.	.	ID=VAR_077546;Note=No effect on affinity for testosterone%3B no effect on affinity for NADPH%3B no effect on Vmax. C->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10898110;Dbxref=PMID:10898110	
P31213	UniProtKB	Natural variant	30	30	.	.	.	ID=VAR_077547;Note=Increased affinity for testosterone%3B increased affinity for NADPH%3B decreased Vmax. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10898110;Dbxref=PMID:10898110	
P31213	UniProtKB	Natural variant	48	48	.	.	.	ID=VAR_077548;Note=Increased affinity for testosterone%3B increased affinity for NADPH%3B decreased Vmax. P->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10898110;Dbxref=PMID:10898110	
P31213	UniProtKB	Natural variant	49	49	.	.	.	ID=VAR_013104;Note=Increased affinity for testosterone%3B no effect on affinity for NADPH%3B increased Vmax%3B no effect on affinity for testosterone when associated with L-89%3B no effect on affinity for NADPH when associated with L-89%3B increased Vmax when associated with L-89. A->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10501358,ECO:0000269|PubMed:10898110,ECO:0000269|PubMed:14560315,ECO:0000269|PubMed:15770495,ECO:0000269|PubMed:16181229,ECO:0000269|Ref.4;Dbxref=dbSNP:rs9282858,PMID:10501358,PMID:10898110,PMID:14560315,PMID:15770495,PMID:16181229	
P31213	UniProtKB	Natural variant	51	51	.	.	.	ID=VAR_077549;Note=No effect on affinity for testosterone%3B increased affinity for NADPH%3B decreased Vmax. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10898110;Dbxref=PMID:10898110	
P31213	UniProtKB	Natural variant	55	55	.	.	.	ID=VAR_013105;Note=In PPSH. L->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8768837;Dbxref=PMID:8768837	
P31213	UniProtKB	Natural variant	85	85	.	.	.	ID=VAR_013130;Note=In PPSH. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10718838;Dbxref=PMID:10718838	
P31213	UniProtKB	Natural variant	89	89	.	.	.	ID=VAR_013131;Note=No effect on affinity for testosterone%3B no effect on affinity for NADPH%3B decreased Vmax%3B no effect on affinity for testosterone when associated with T-49%3B no effect on affinity for NADPH when associated with T-49%3B increased Vmax when associated with T-49%3B decreased affinity for testosterone when associated with M-187%3B increased affinity for NADPH when associated with M-187%3B decreased Vmax when associated with M-187%3B no effect on affinity for testosterone when associated with L-234%3B increased affinity for NADPH when associated with L-234%3B decreased Vmax when associated with L-234. V->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10898110,ECO:0000269|PubMed:11927504,ECO:0000269|PubMed:12843198,ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:15770495,ECO:0000269|PubMed:16181229,ECO:0000269|Ref.3,ECO:0000269|Ref.4;Dbxref=dbSNP:rs523349,PMID:10898110,PMID:11927504,PMID:12843198,PMID:15489334,PMID:15770495,PMID:16181229	
P31213	UniProtKB	Natural variant	113	113	.	.	.	ID=VAR_022302;Note=L->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.4;Dbxref=dbSNP:rs28383048	
P31213	UniProtKB	Natural variant	115	115	.	.	.	ID=VAR_013106;Note=In PPSH. G->D;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10718838,ECO:0000269|PubMed:15528927,ECO:0000269|PubMed:8626825;Dbxref=PMID:10718838,PMID:15528927,PMID:8626825	
P31213	UniProtKB	Natural variant	123	123	.	.	.	ID=VAR_025854;Note=In PPSH. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16098368;Dbxref=PMID:16098368	
P31213	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_025855;Note=In PPSH. Q->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15770495;Dbxref=PMID:15770495	
P31213	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_025851;Note=In PPSH. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16181229;Dbxref=PMID:16181229	
P31213	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_013107;Note=In PPSH. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7554313;Dbxref=PMID:7554313	
P31213	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_025856;Note=In PPSH. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15770495;Dbxref=PMID:15770495	
P31213	UniProtKB	Natural variant	181	181	.	.	.	ID=VAR_025852;Note=In PPSH. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16181229;Dbxref=PMID:16181229	
P31213	UniProtKB	Natural variant	183	183	.	.	.	ID=VAR_013108;Note=In PPSH. G->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15770495,ECO:0000269|PubMed:8626825;Dbxref=PMID:15770495,PMID:8626825	
P31213	UniProtKB	Natural variant	187	187	.	.	.	ID=VAR_077550;Note=No effect on affinity for testosterone%3B increased affinity for NADPH%3B decreased Vmax%3B decreased affinity for testosterone when associated with L-89%3B increased affinity for NADPH when associated with L-89%3B decreased Vmax when associated with L-89. T->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10898110;Dbxref=PMID:10898110	
P31213	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_077551;Note=No effect on affinity for testosterone%3B increased affinity for NADPH%3B increased Vmax. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10898110;Dbxref=PMID:10898110	
P31213	UniProtKB	Natural variant	196	196	.	.	.	ID=VAR_013109;Note=In PPSH. G->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15770495,ECO:0000269|PubMed:16181229,ECO:0000269|PubMed:9745434;Dbxref=PMID:15770495,PMID:16181229,PMID:9745434	
P31213	UniProtKB	Natural variant	197	197	.	.	.	ID=VAR_013110;Note=In PPSH. E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10999800;Dbxref=PMID:10999800	
P31213	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_013132;Note=In PPSH. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9208814;Dbxref=PMID:9208814	
P31213	UniProtKB	Natural variant	203	203	.	.	.	ID=VAR_059791;Note=G->S;Dbxref=dbSNP:rs9332961	
P31213	UniProtKB	Natural variant	207	207	.	.	.	ID=VAR_025857;Note=In PPSH. A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15770495;Dbxref=PMID:15770495	
P31213	UniProtKB	Natural variant	212	212	.	.	.	ID=VAR_013111;Note=In PPSH. P->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10718838,ECO:0000269|PubMed:10999800;Dbxref=PMID:10718838,PMID:10999800	
P31213	UniProtKB	Natural variant	224	224	.	.	.	ID=VAR_059792;Note=L->H;Dbxref=dbSNP:rs9332963	
P31213	UniProtKB	Natural variant	224	224	.	.	.	ID=VAR_037585;Note=L->M;Dbxref=dbSNP:rs9332963	
P31213	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_037586;Note=In PPSH%3B also in individuals with micropenis%3B increased affinity for testosterone%3B increased affinity for NADPH%3B decreased Vmax. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10898110,ECO:0000269|PubMed:12843198,ECO:0000269|PubMed:15064320;Dbxref=dbSNP:rs9332964,PMID:10898110,PMID:12843198,PMID:15064320	
P31213	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_013112;Note=In PPSH. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9843052;Dbxref=PMID:9843052	
P31213	UniProtKB	Natural variant	231	231	.	.	.	ID=VAR_013113;Note=In PPSH. H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9745434;Dbxref=PMID:9745434	
P31213	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_077552;Note=Increased affinity for testosterone%3B increased affinity for NADPH%3B decreased Vmax%3B no effect on affinity for testosterone when associated with L-89%3B increased affinity for NADPH when associated with L-89%3B decreased Vmax when associated with L-89. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10898110;Dbxref=PMID:10898110	
P31213	UniProtKB	Natural variant	235	235	.	.	.	ID=VAR_025853;Note=In PPSH. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16181229;Dbxref=PMID:16181229	
P31213	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_013133;Note=In PPSH. S->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10718838;Dbxref=PMID:10718838	
P31213	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_013134;Note=In PPSH. R->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10718838,ECO:0000269|PubMed:16181229;Dbxref=dbSNP:rs9332967,PMID:10718838,PMID:16181229	
P31213	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_005609;Note=In PPSH. R->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1522235,ECO:0000269|PubMed:15528927,ECO:0000269|PubMed:15770495,ECO:0000269|PubMed:8626825;Dbxref=PMID:1522235,PMID:15528927,PMID:15770495,PMID:8626825	
